Invesco’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.51M Sell
182,455
-23,547
-11% -$244K ﹤0.01% 2676
2025
Q4
$2.55M Sell
206,002
-174,278
-46% -$1.87M ﹤0.01% 2516
2025
Q3
$3.35M Sell
380,280
-184,994
-33% -$1.44M ﹤0.01% 2406
2025
Q2
$3.61M Sell
565,274
-182,685
-24% -$1.05M ﹤0.01% 2342
2025
Q1
$3.64M Sell
747,959
-791,948
-51% -$6.56M ﹤0.01% 2303
2024
Q4
$14.7M Buy
1,539,907
+638,995
+71% +$5.86M ﹤0.01% 1641
2024
Q3
$7.52M Buy
900,912
+3,942
+0.4% +$35.8K ﹤0.01% 1992
2024
Q2
$6.12M Buy
896,970
+4,091
+0.5% +$17.6K ﹤0.01% 2075
2024
Q1
$2.26M Buy
892,879
+601,003
+206% +$1.35M ﹤0.01% 2610
2023
Q4
$701K Sell
291,876
-11,109
-4% -$26.1K ﹤0.01% 3049
2023
Q3
$1.03M Sell
302,985
-486,870
-62% -$2.7M ﹤0.01% 2847
2023
Q2
$5.81M Sell
789,855
-73,424
-9% -$681K ﹤0.01% 2159
2023
Q1
$8.94M Sell
863,279
-1,263,340
-59% -$15.3M ﹤0.01% 1883
2022
Q4
$25.1M Buy
2,126,619
+1,145,544
+117% +$17.7M 0.01% 1263
2022
Q3
$20.6M Buy
981,075
+160,476
+20% +$4.47M 0.01% 1301
2022
Q2
$25.5M Sell
820,599
-66,763
-8% -$2.28M 0.01% 1234
2022
Q1
$36.4M Sell
887,362
-102,900
-10% -$4.54M 0.01% 1153
2021
Q4
$43M Buy
990,262
+261,955
+36% +$11.9M 0.01% 1113
2021
Q3
$36.5M Sell
728,307
-25,522
-3% -$1.55M 0.01% 1194
2021
Q2
$47.5M Sell
753,829
-292,962
-28% -$18.8M 0.01% 1097
2021
Q1
$97.3M Sell
1,046,791
-28,283
-3% -$2.9M 0.03% 821
2020
Q4
$96.3M Buy
1,075,074
+415,547
+63% +$38.1M 0.03% 740
2020
Q3
$68.1M Sell
659,527
-142,510
-18% -$15.4M 0.02% 799
2020
Q2
$63.4M Sell
802,037
-110,187
-12% -$8.21M 0.02% 797
2020
Q1
$52.8M Buy
912,224
+303,427
+50% +$17.5M 0.02% 776
2019
Q4
$32.8M Sell
608,797
-186,464
-23% -$10.1M 0.01% 1170
2019
Q3
$41.6M Sell
795,261
-67,604
-8% -$3.15M 0.01% 1080
2019
Q2
$41.7M Buy
862,865
+87,799
+11% +$4.21M 0.01% 1098
2019
Q1
$39.2M Sell
775,066
-122,522
-14% -$7.23M 0.01% 929
2018
Q4
$53.2M Sell
897,588
-231,845
-21% -$14.9M 0.02% 736
2018
Q3
$74.4M Buy
1,129,433
+309,139
+38% +$18M 0.02% 684
2018
Q2
$41.4M Buy
820,294
+53,218
+7% +$2.77M 0.01% 912
2018
Q1
$40.4M Sell
767,076
-13,955
-2% -$696K 0.02% 835
2017
Q4
$36.3M Sell
781,031
-61,779
-7% -$2.6M 0.01% 909
2017
Q3
$34.1M Sell
842,810
-128,566
-13% -$4.65M 0.01% 934
2017
Q2
$32.9M Buy
971,376
+630,173
+185% +$19.5M 0.01% 968
2017
Q1
$9.91M Buy
341,203
+26,225
+8% +$798K ﹤0.01% 1555
2016
Q4
$10.3M Sell
314,978
-138,712
-31% -$4.16M ﹤0.01% 1520
2016
Q3
$14.3M Buy
453,690
+46,762
+11% +$1.36M ﹤0.01% 1291
2016
Q2
$11.4M Buy
406,928
+52,740
+15% +$2.07M ﹤0.01% 1375
2016
Q1
$12.9M Sell
354,188
-72,358
-17% -$2.56M 0.01% 1312
2015
Q4
$17.1M Sell
426,546
-93,764
-18% -$3.27M 0.01% 1222
2015
Q3
$14.8M Sell
520,310
-50,887
-9% -$1.68M 0.01% 1274
2015
Q2
$18.8M Sell
571,197
-23,251
-4% -$721K 0.01% 1245
2015
Q1
$17.1M Sell
594,448
-21,803
-4% -$625K 0.01% 1275
2014
Q4
$16.8M Buy
616,251
+51,494
+9% +$1.23M 0.01% 1264
2014
Q3
$12M Buy
564,757
+16,408
+3% +$376K ﹤0.01% 1451
2014
Q2
$12.3M Sell
548,349
-71,052
-11% -$1.65M ﹤0.01% 1447
2014
Q1
$15.7M Buy
619,401
+107,106
+21% +$2.71M 0.01% 1311
2013
Q4
$11.8M Buy
512,295
+94,443
+23% +$1.97M ﹤0.01% 1452
2013
Q3
$7.96M Buy
417,852
+21,392
+5% +$382K ﹤0.01% 1607
2013
Q2
$5.72M Buy
+396,460
New +$5.74M ﹤0.01% 1762

Other funds holding EBS